Bio-Path Holdings Reports Fiscal Year 2014 Operational and Financial Results
Bio-Path Holdings reported operational and financial results for the year ended December 31, 2014. In a release on March 17, the Company noted that 2014 OPERATIONAL AND FINANCIAL HIGHLIGHTS include:. -In the fourth quarter of 2014, Bio-Path successfully completed Cohort 6 of its Phase 1 clinical trial evaluating its lead compound, Liposomal Grb-2, in blood…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News